1. Adipose-tissue derived porcine mesenchymal stem cells efficiently ameliorate CCl4-induced acute liver failure in mice
- Author
-
Yue Zhang, Liang Qiao, Shourong Liu, Keyang Xu, Ruihong Guo, Xiawei Jiang, Tiantian Wang, Xiaoyu Wu, Xiaoli Hou, and Xiaoping Pan
- Subjects
0301 basic medicine ,Cluster of differentiation ,Growth factor ,medicine.medical_treatment ,digestive, oral, and skin physiology ,Clinical Biochemistry ,Mesenchymal stem cell ,Biomedical Engineering ,Albumin ,Adipose tissue ,Bioengineering ,Cell Biology ,Biology ,Andrology ,03 medical and health sciences ,Cytokeratin ,030104 developmental biology ,0302 clinical medicine ,030220 oncology & carcinogenesis ,medicine ,Original Article ,Gene ,Survival rate ,Biotechnology - Abstract
Adipose tissue derived mesenchymal stem cells (ADMSCs) may be an attractive therapeutic source for acute liver injury because of their high accessibility and non-invasiveness. Here, we investigated the therapeutic potentials of porcine ADMSCs for acute liver failure (ALF). The morphology, differentiation potential, expression patterns of cell surface markers and liver-specific genes were compared between the ADMSCs derived from the pigs with or without ALF. For therapeutic studies, the expanded porcine ADMSCs from either ALF pig (ALF-ADMSCs) or healthy control pig (Nor-ADMSCs) of passage 3 were transplanted into CCl(4)-induced ALF mice, and the liver histology and functional tests were performed at days 1, 7, 14, and 21 after cell transplantation. ALF-ADMSCs expressed higher mRNA level of hepatic growth factor (HGF) than the Nor-ADMSCs. Both ALF-ADMSCs and Nor-ADMSCs improved liver histology, functions, and mouse survival rate. Higher level of porcine hepatocyte-specific genes was seen in the livers of ALF-ADMSCs transplanted mice as compared to the Nor-ADMSCs transplanted mice. In particular, ALF-ADMSCs transplanted mice expressed significantly higher level of albumin and cytokeratin 18 in the liver tissues as compared to the Nor-ADMSCs transplanted mice. ALF-ADMSCs might be superior to Nor-ADMSCs in the treatment of ALF as the former possesses stronger hepatic differentiation potential.
- Published
- 2020
- Full Text
- View/download PDF